HHS peptide policy: what it says, and what it does not. BPC-157, epitalon, KPV, MOTS-c, semax, TB-500.

HHS’s new peptide policy: what it says, and what it does not

Jaber Niknam28 October 2026

HHS has filed an enforcement discretion policy covering six peptides compounded under 503A. Here is what it allows, what it requires, what it is not, and where AccuMix stands. ... Read More

AccuMix Pharmacy is now a member of the American Pharmacists Association (APhA)

AccuMix Pharmacy joins the American Pharmacists Association

Jaber Niknam24 October 2026

AccuMix Pharmacy is now a member of the American Pharmacists Association (APhA), alongside ACA, the Alliance for Pharmacy Compounding and PCCA. ... Read More

AccuMix Pharmacy is now licensed in Oklahoma

Jaber Niknam22 October 2026

AccuMix Pharmacy has received its Oklahoma non-resident pharmacy license: 40 states and Washington, DC, with 9 more in process. ... Read More

Graphic comparing a 503A compounding pharmacy with a 503B outsourcing facility

503A vs 503B Compounding Pharmacies: What the Difference Means for You

Jaber Niknam22 October 2026

503A pharmacies and 503B outsourcing facilities are regulated differently and serve different needs. A plain-language guide to who inspects each, the prescription rule, and what to ask. ... Read More

HHS’s new peptide policy: what it says, and what it does not

AccuMix Pharmacy joins the American Pharmacists Association

AccuMix Pharmacy is now licensed in Oklahoma

503A vs 503B Compounding Pharmacies: What the Difference Means for You

Pharmacy news, straight to your inbox.